Description

Howie and Harlan discuss a concerning new COVID-19 variant, the discovery casting doubt on a major fish-oil study, and the need for new models of funding research.

Links:

"New Omicron subvariant Centaurus could be the most immune-evasive yet, expert warns"

"Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia"

"Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy"

Learn more about the MBA for Executives program at Yale SOM.

Email Howie and Harlan comments or questions.